Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Transcode Therapeutics Inc
RNAZ
Healthcare
Biotechnology
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. The Company is focused on treating cancer through the design and delivery of ribonucleic acid (RNA) therapeutics based on its TTX nanoparticle platform. The Company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique...
, well-documented biomarker of metastasis. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 (PD-L1), and two indication agnostic programs, TTX-RIGA, an RNA-based agonist of the retinoic acid- inducible gene I (RIG-I), targeting activation of innate immunity in the tumor microenvironment; and TTX- CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells. The Company’s pipeline also includes TTX-mRNA, a tumor-type specific mRNA-based platform for the development of cancer vaccines.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RNAZ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(279)
•••
whytestocks
X
Post by
whytestocks
on Sep 05, 2024 12:00pm
TransCode Therapeutics Awarded $2 Million NIH Grant to Suppo
News; $RNAZ TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead CandidateBOSTON, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ
...more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 1:49am
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Advancing Targete
https://beyondspx.com/2024/08/02/transcode-therapeutics-inc-nasdaqrnaz-advancing-targeted-rna-therapeutics-through-innovative-delivery/
(279)
•••
whytestocks
X
Post by
whytestocks
on Jun 10, 2024 10:00am
Nasdaq Determines That TransCode Therapeutics Has Regained C
News; $RNAZ Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing RequirementsBOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 20, 2024 8:00am
New Press Release - TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode's RIG-I Agonist Immunotherapeutic
BOSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, reported publication of United States Patent Application titled, “Nanoparticles and Template Directed RIG-I Agonist...
read article.
(394)
•••
Tarbaby
X
Post by
Tarbaby
on Feb 08, 2024 10:39am
Total Shares Issued
I believe Stockhouse is wrong in their share count. The company recently issued ove 7 million shares in a money raise. But the msrket cap is still extremely low for a cutting edge cancer study.. Its a
...more
(394)
•••
Tarbaby
X
Post by
Tarbaby
on Feb 08, 2024 10:35am
Total Shares Issued
I believe Stockhouse is wrong in their share count. The company recently issued ove 7 million shares in a money raise. But the msrket cap is still extremely low for a cutting edge cancer study.. Its a
...more
(394)
•••
Tarbaby
X
Post by
Tarbaby
on Feb 07, 2024 1:03pm
Collaboration Looks Good
I teally like the collaboration agreement. It really lends credibility to their cancer treatment protocol... Good work team..! Im a buyer. Cheers
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 31, 2024 4:05pm
New Press Release - Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders' Equity Requirement and Continued Listing on The Nasdaq Stock Market
BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from the NASDAQ Stock Market LLC (Nasdaq) that the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 29, 2024 8:30am
New Press Release - TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
Project to test combination of TransCode’s proprietary TTX delivery platform and Debiopharm’s drug delivery technologies BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jan 22, 2024 4:45pm
New Press Release - TransCode Therapeutics Announces Closing of $7.25 Million Public Offering
BOSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously announced public offering of an aggregate of 5,942,623...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 19, 2024 1:33pm
RNAZ....2 x's tap on L.O.D 74
I say 56 close
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 19, 2024 10:51am
RNAZ..... This ain't the bottom
Bets ????
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 19, 2024 7:24am
RNAZ....... Fryday
Literally
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2024 3:41pm
RNAZ....P.O being priced
who know at what price This is all smoke & mirrors
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 18, 2024 10:50am
RNAZ....total manip & MM antics
Do some reasearch ....LoL
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?